Live Your Vision’s Altimmune ALT Stock Holding History

Live Your Vision’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$0	Hold	26	–	–	﹤0.01%	266
2018 Q4	$0	Hold	26	–	–	﹤0.01%	251
2018 Q3	$0	Hold	26	–	–	﹤0.01%	266
2018 Q2	$0	Hold	26	–	–	﹤0.01%	311
2018 Q1	$1K	Hold	26	–	–	﹤0.01%	250
2017 Q4	$1K	Hold	26	–	–	﹤0.01%	247
2017 Q3	$2K	Hold	26	–	–	﹤0.01%	242
2017 Q2	$2K	Hold	26	–	–	﹤0.01%	263
2017 Q1	$6K	Hold	26	–	–	﹤0.01%	215
2016 Q4	$25K	Hold	26	–	–	0.01%	129
2016 Q3	$22K	Buy	+26	New	+$20.4K	0.01%	132
2015 Q4	–	Sell	-26	Closed	-$10K	–	78
2015 Q3	$10K	Buy	+26	New	+$12.3K	﹤0.01%	180

Other funds holding ALT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Live Your Vision's ALT Position: Q1 2019 in Review

Live Your Vision held its Altimmune (ALT) position steady in Q1 2019 at 26 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #266.

Live Your Vision first reported a position in ALT in Q3 2015 and has held it in 12 quarters since. The position peaked at $25K in Q4 2016. 21 funds tracked by Wall St. Rank hold ALT as of Q1 2019.

Live Your Vision held 26 shares of Altimmune worth $0 as of Q1 2019.
Live Your Vision left its Altimmune share count unchanged in Q1 2019.
Altimmune made up ﹤0.01% of Live Your Vision's portfolio in Q1 2019, its #266 holding.
Live Your Vision first reported a position in Altimmune in Q3 2015 and has held it in 12 quarters since.
Live Your Vision's Altimmune position peaked at $25K in Q4 2016.
21 funds tracked by Wall St. Rank held Altimmune as of Q1 2019.

Based on Live Your Vision's 13F filing for Q1 2019, filed 25 Apr 2019.